World AIDS Day is observed every year on December 1, and in 2026 it falls on a Tuesday. Founded in 1988, it was the first international day for global health, according to UNAIDS. The 2026 theme, set by UNAIDS, is access, with the slogan "Ending AIDS starts with access."
The day combines remembrance with progress: 32.1 million people were receiving HIV treatment at the end of 2025, and new prevention tools keep arriving.
Why World AIDS Day Exists
World AIDS Day is an annual observance on December 1 that raises awareness of HIV and AIDS and remembers the people lost to it. It was first held on December 1, 1988.
The idea was conceived in August 1987 by James W. Bunn and Thomas Netter, two public information officers with the World Health Organization's Global Programme on AIDS in Geneva. They proposed it to the programme's director, Dr. Jonathan Mann, who approved it.
The date was recommended because it fell after the U.S. elections and before the Christmas holidays, which was expected to draw the most news coverage.
What HIV and AIDS Are
HIV, the human immunodeficiency virus, is a virus that attacks the immune system. AIDS, or acquired immunodeficiency syndrome, is the most advanced stage of untreated HIV infection. Modern HIV medicine, called antiretroviral therapy, keeps the virus at very low levels in the body.
The Red Ribbon
The red ribbon is the international symbol of AIDS awareness. It was created in 1991 by the Visual AIDS Artists' Caucus, a group of artists in New York.
The artists met in April and May of 1991 and used yellow ribbons as their inspiration. Red was chosen for its connection to blood and to passion, meaning both anger and love.
The group never copyrighted the ribbon, so anyone could use it. It appeared at the 45th annual Tony Awards in June 1991, where Jeremy Irons was among the first presenters to wear it.
The AIDS Memorial Quilt
The AIDS Memorial Quilt is a growing memorial made of fabric panels, each made in memory of a person who died of AIDS. Activist Cleve Jones conceived the idea in November 1985 while planning San Francisco's annual candlelight march for Harvey Milk and George Moscone. Marchers wrote the names of people lost to AIDS on placards and taped them to the walls of the San Francisco Federal Building, where they looked like a patchwork quilt.
The NAMES Project Foundation was formally organized in San Francisco in June 1987. The Quilt was first displayed on the National Mall in Washington, D.C., on October 11, 1987, with 1,920 panels. Each panel measures about 3 by 6 feet (90 by 180 cm).
The Quilt now has nearly 50,000 panels dedicated to more than 110,000 people, and it is in the care of the National AIDS Memorial in San Francisco.
The 2026 Theme: Access
UNAIDS, the Joint United Nations Programme on HIV/AIDS, has set "access" as the theme of World AIDS Day 2026. UNAIDS says that 2026 also marks 30 years since the programme was founded.
UNAIDS Executive Director Winnie Byanyima said: "The science has done its part. The system must now do ours." UNAIDS reports that nearly 9 million people living with HIV still had no access to treatment in 2025, and that only 55% of children living with HIV were on treatment.
HIV Around the World: The Latest Figures
UNAIDS publishes global figures every year, and its latest fact sheet covers 2025. The numbers show large gains since the peak of the epidemic, and they also show how much work remains.
| Measure (2025) | Figure |
|---|---|
| People living with HIV | 41.0 million |
| People receiving treatment | 32.1 million (78% of all people living with HIV) |
| People living with HIV who knew their status | 88% |
| People on treatment with suppressed virus | 95% |
| New HIV infections | 1.2 million |
| AIDS-related deaths | 570,000 |
New infections have fallen 42% since 2010 and 65% since their 1994 peak. AIDS-related deaths have fallen 57% since 2010 and 73% since their 2004 peak.
UNAIDS also reports that the world is off track for its 2030 targets, and that external HIV financing dropped 18% in 2025, the largest fall in almost two decades. More than 55 countries have committed to raise their own contributions.
U=U: Undetectable Means Untransmittable
U=U is a public health message that stands for "undetectable equals untransmittable." The U.S. government's HIV.gov says a person who takes HIV medicine as prescribed and keeps an undetectable viral load will not transmit HIV to their HIV-negative partners through sex.
Viral load is the amount of HIV in a milliliter of blood. HIV.gov says almost everyone who takes HIV medicine as prescribed can reach an undetectable level, usually within six months of starting treatment.
U=U applies to sexual transmission, and an undetectable viral load does not protect against other sexually transmitted infections. HIV medicine controls the virus but does not cure it, so treatment continues.
PrEP and the Twice-a-Year Shot
PrEP, or pre-exposure prophylaxis, is medicine taken by people who do not have HIV to lower their chance of getting it.
On June 18, 2025, the U.S. Food and Drug Administration approved lenacapavir, sold as Yeztugo, as PrEP. It is given by injection under the skin once every six months. The U.S. Centers for Disease Control and Prevention published a recommendation for it on September 18, 2025.
Two large trials supported the approval. In PURPOSE 1, which enrolled mainly women, no infections were seen in the lenacapavir group over 52 weeks, according to the CDC's report. In PURPOSE 2, which enrolled mainly men, lenacapavir reduced infections by 96% compared with no PrEP and by 89% compared with daily PrEP pills.
On July 14, 2025, the World Health Organization recommended injectable lenacapavir as an additional PrEP option, given twice a year. UNAIDS says lenacapavir had reached more than 50,000 people in nine sub-Saharan African countries by the end of June 2026, and that its price for lower-income countries will fall to US$40 per person per year from 2027.
The "Berlin Patient" and Other Cure Cases
A small number of people have had their HIV go into long-term remission after stem cell transplants given for blood cancers. The first was Timothy Ray Brown, known as the "Berlin patient," whose donor carried a rare gene variant called CCR5-delta 32 that makes cells resistant to HIV. He died of recurrent leukemia in 2020.
The World Health Organization reported in 2024 that four other people had similar transplants and remained in sustained remission. A 2023 case used a donor without the variant and is also in prolonged remission, and a seventh case, a 60-year-old German man transplanted in 2015, was presented at the AIDS 2024 conference in Munich. He stopped HIV medicine in late 2018, and HIV has not been detected since.
These cases are not a treatment anyone can receive. WHO states that stem cell transplants are complex, carry significant risk and have been reserved for patients who need them because of cancer. The cases do give researchers leads for approaches such as gene editing.





